Material
T he crucial factor determining the outcome of Cryptococcus neoformans infection is the immune status of the host, with cryptococcal disease occurring most commonly in those with impaired immunity, particularly HIV/AIDS-associated CD4 T cell deficiency. The central importance of T cells in host defense against C. neoformans has been established in murine models (1, 2) ; however, the role of B cells has not been definitively established. Multiple laboratories have demonstrated that mAbs to the C. neoformans capsular polysaccharide glucuronoxylomannan (GXM) can protect mice against lethal C. neoformans infection (3-7) by a variety of mechanisms (8) (9) (10) (11) (12) (13) (14) . GXM-binding murine mAbs generated from the adaptive response to GXM are derived from a highly restricted B cell repertoire expressing the Ig V region H chain (V H ) gene 7183 (15, 16) . Similarly, human GXM-binding mAbs use V H 3 genes with structural homology to mouse 7183 genes (17, 18) . Because V H 3 genes are depleted in HIV infection, it has been hypothesized that a hole in the Ab repertoire could increase susceptibility to cryptococcosis (19) .
In addition to V H 3-expressing B cells, IgM memory (CD27 +

IgM
+ IgD 2 ) B cells are also depleted in HIV infection (20) . IgM memory B cells produce "naturally occurring" IgM (21) that has an intrinsic ability to bind conserved microbial determinants, such as a-and b-glucans, which are present in most fungal cell walls (22) . Because natural IgM is produced in the absence of Ag stimulation, it is a part of the innate immune system that is considered to provide a ready-made pathogen defense (23) . It has previously been shown that peripheral blood IgM memory B cell levels were lower in HIV-infected individuals who developed cryptococcal disease than in those who did not (24) and that HIVinfected individuals have lower levels of serum GXM-binding IgM than do HIV-uninfected individuals (25, 26) . In mice, IgM deficiency was associated with increased susceptibility to pulmonary C. neoformans infection and a reduced level of alveolar macrophage phagocytosis of C. neoformans that increased after reconstitution with natural mouse (nonimmune) IgM (27) . Natural mouse IgM bound to b-1,3-glucans on Pneumocystis and A. fumigatus and enhanced immunity to Pneumocystis (22) . Furthermore, a natural mAb to keratin protected mice against Candida albicans (28) , and mAbs to laminarin (a b-1,3-glucan) bound to C. albicans and C. neoformans and protected mice from lethal infection with these fungi (14, 29) . Although soluble GXM-elicited mAbs protect mice against C. neoformans, the question of whether B cells contribute to host defense against C. neoformans is unresolved. One study found no difference in C. neoformans lethality in B cell-depleted and B cell-sufficient mice (30) , whereas another linked resistance to C. neoformans in T cell-deficient mice to B cells (31) . B cells were the predominant cell type in the lungs of immunocompetent C. neoformans-infected mice (32) , and pulmonary C. neoformans was more lethal in B cell-deficient than in B cell-sufficient and xid mice (33, 34) . The latter mice lack B-1 B cells and natural IgM, suggesting a beneficial role for these constituents in protection against C. neoformans.
Mature B cells can be classified into follicular B, marginal zone B, and B-1 B cells, with follicular and marginal zone B cells being commonly referred to as B-2 cells (35) . B-1 B cells consist of B-1a and B-1b subsets, which are distinguished by surface expression of CD5 (36 (38) , reside predominantly in the pleural and peritoneal cavities, but they are also present in the spleen (23) . These cells can also migrate to sites of inflammation and differentiate into mononuclear phagocytes (39), and they have been shown to kill C. neoformans in vitro (40) . Recently, resistance of B cell-deficient (mMT) mice to A. fumigatus was linked to the discovery of B-1 B cells in these mice (41) . Although B-1 cells have been linked to antifungal activity against C. neoformans (40, 42), their role in host defense has not been formally established.
In this study, we analyzed the mouse B cell response to pulmonary C. neoformans infection and the V H repertoire of C. neoformans-selected and unselected B-1 and B-2 B cell populations. Our data show that peritoneal cavity B-1a B cells had the most C. neoformans-binding cells. C. neoformans-selected B-1 cells secreted IgM that bound to laminarin and C. neoformans cells, and they used highly restricted V H 11 and V H 12 genes that are known to confer specificity for phosphatidylcholine (PC). A mechanistic role for B-1 B cells was established in B-1 B celldepleted mice, which had higher lung and brain fungal burdens and less alveolar macrophage phagocytosis of C. neoformans than did control and B-1a B cell-reconstituted mice. In summary, our findings reveal a role for the B-1a B cell subset during pulmonary C. neoformans infection in mice.
Materials and Methods
Mice
Six-to eight-wk-old C57BL/6 mice obtained from the National Cancer Institute (Charles River Laboratories) and housed in the Institute for Animal Studies of the Albert Einstein College of Medicine were used. All mouse experiments were conducted with prior approval from the Animal Care and Use Committee, following established guidelines.
C. neoformans strains and inocula for infection
Serotype D C. neoformans, strain 24067 (American Type Culture Collection), extensively used in mice to study immunity to C. neoformans (43, 44) was used. GFP-labeled 24067 was provided by Dr. A. Alspaugh (Duke University), and acapsular Cap67 (ATCC 52817) was provided by Dr. A. Casadevall (Albert Einstein College of Medicine). Cap67 was labeled with 10 mg/ml Uvitex 2B dye (Polysciences, Eppelheim, Germany). For some experiments, C. neoformans was heat-killed at 65˚C for 30 min. C. neoformans cultures were grown in Sabouraud dextrose broth (Becton Dickinson) for 52-56 h at 37˚C with agitation. Mice were infected intranasally (i.n.) with 5 3 10 5 CFU unlabeled 24067 in 20 ml PBS as described (27) .
BrdU staining
For BrdU assays, C. neoformans-infected and PBS-treated C57BL/6 mice were injected i.p. with 1 mg BrdU 1 d prior to tissue harvest. At indicated times, mice were killed, and cells from various tissues were harvested. A BrdU flow kit (BD Biosciences) was used as directed to assess BrdU uptake by flow cytometry.
Cell purification, FACS staining, and C. neoformans binding
For isolation of cells from lungs, spleen, and mediastinal lymph nodes (medLNs), tissues were homogenized using a gentleMACS dissociator (Miltenyi Biotec), following the manufacturer's instructions. Peritoneal cavity (PerC) cells were obtained by flushing the peritoneum with saline. Erythrocytes were lysed in RBC lysis buffer. The isolated cells were filtered, resuspended in 1% BSA-PBS, and counted. C. neoformans binding in PerC B cell subsets was detected by flow cytometry based on a previously published method (45) . Aliquots of mouse cells (10 6 ) were incubated with 10 7 CFU heat-killed Uvitex-labeled Cap67 or GFP-expressing 24067 and washed twice with PBS. After blocking with rat anti-mouse CD16/32, immunostaining was performed at 4˚C for 20 min in 1% BSA-PBS using a mixture of CD19-PE-Cy7, B220-allophycocyaninCy7, IgD-allophycocyanin, CD5-PE, and IgM-PerCP (BD Biosciences). Single-color controls and fluorescence minus one controls were included to ensure proper gating. B cell populations were defined as total B (CD19 ). Data were collected on a BD LSR II (Becton Dickinson) flow cytometer. A total of 100,000 events per sample were analyzed. All analyses were performed using FlowJo (Tree Star, Ashland, OR).
ELISPOT
IgM secretion and C. neoformans Ag binding of B cells was determined by ELISPOT assay as previously described (46) . MultiScreen HA membrane plates (Millipore) were coated with goat anti-mouse IgM (5 mg/ml), heatkilled Cap67 and 24067 (10 7 CFU), laminarin (10 mg/ml; Sigma-Aldrich), and GXM (10 mg/ml), purified as described (47) in PBS and incubated overnight at 4˚C. Plates were blocked with 1% BSA-RPMI 1640 for 2 h at 37˚C. Isolated splenic, PerC, lung, and medLN cells (ranging from 10 5 to 10 2 per well) from C. neoformans-infected mice were added to the plate and incubated for 16 h at 37˚C, 5% CO 2 . In ELISPOT assays to test the specificity of C. neoformans-selected B cells, B-1a and B-1b cells were pooled together and assayed as the B-1 fraction owing to small numbers of C. neoformans-selected cells. After incubation, cells were discarded and biotinylated anti-mouse IgM Ab (1:5000; SouthernBiotech) was added for 2 h at 37˚C, followed by streptavidin-HRP (1:100; BD Biosciences) for 1 h at room temperature. Substrate 3-amino-9-ethylcarbazole (BD Biosciences) was added for 30 min at room temperature. Color development was stopped with water and plates were dried overnight. Spots were counted using an ELISPOT reader (Autoimmun Diagnostika).
Single cell sorting of C. neoformans-binding B cell subsets B-1a, B-1b, and B-2 cells identified as capsular (GFP-24067) or acapsular (Uvitex-Cap67) C. neoformans-binding populations by FACS were isolated by sorting and referred to as C. neoformans-selected populations. A separate aliquot of B cells stained with unlabeled capsular or acapsular C. neoformans was used to determine gating for C. neoformans-selected cells. C. neoformans-selected and unselected B-1a, B-1b, and B-2 cells were purified using a FACSAria cell sorter (BD Biosciences) and collected as single cells directly in 96-well PCR plates containing 4 ml ice-cold lysis buffer (0.53 endonuclease-free PBS supplemented with 10 U RNAse inhibitor) on dry ice, using established procedures (48, 49) . A no-cell control was included in each plate. Single B cells were sorted according to surface marker expression patterns applying forward light scatter-H/forward light scatter-W-based duplet discrimination and single cell sort mask settings. Postsort reanalysis of the B cell subpopulations by FACS revealed $98% purity.
Single cell RT-PCR and Ig gene amplification
cDNA was synthesized from sorted single B cells in a final volume of 20 ml in the original 96-well sorting plate. Pooled H chain C region-specific reverse transcription primers were used at a final concentration 0.15 mM each. The reverse transcription primers used, reaction composition, and cycling conditions were as previously described (50) . IgH V gene transcripts were amplified by touchdown nested PCR using 5 ml unpurified cDNA as template. The 59 IgV H family-specific external and internal primer mixes, 39 C H primers, reaction compositions, and cycling parameters used for nested PCRs were as reported (50) . The amplified products were analyzed on a 1% agarose gel.
Sequencing and sequence analysis of the Ig V H regions
RT-PCR amplified products were column purified (Qiagen) and sequenced directly (Genewiz) using a 39 J H antisense primer, as previously described (50) . Sequences were analyzed using MacVector (with Assembler) software (version 12.0.2). Ig gene/family assignment for the expressed V H genes was done using ImMunoGeneTics (http://www.imgt.org/) and IgBLAST (http://www.ncbi.nlm.nih.gov/igblast/) germline databases. Framework region/CDR assignments and codon numbering were according to the Kabat system. Sequence analysis was restricted to the sequence internal to the 59 and 39 internal primers. The D H genes were assigned as previously described, wherein at least five nucleotides had to match germline D H gene sequence (51) . Any nucleotides that could not be assigned to a coding sequence or palindromic addition were considered nontemplate-encoded (N) nucleotides.
Accession numbers
The nucleotide sequences of the Ig genes expressed by the single cells listed in Supplemental Table I have been deposited in GenBank (http://www.ncbi. nlm.nih.gov/GenBank/index.html). The following accession numbers were provided: JX120180-JX120361.
B-1 cell depletion
Because B-1 cells circulate within peritoneal and pleural cavities, B-1 cells were depleted from both cavities (52) . We adapted a protocol described by Murakami et al. (53) wherein hypotonic shock results in selective depletion of self-replenishing B-1 cells in the peritoneal cavity, but not in the spleen (54, 55) . Briefly, 2-to 4-wk-old C57BL/6 mice were injected i.p. and into the thoracic cavity with 0.5 and 0.1 ml double distilled H 2 O, respectively, every week until infection. At 4-8 wk, mice received 1 and 0.2 ml double distilled H 2 O i.p. and into the thoracic cavity, respectively. Control groups were injected with PBS at all times. Depletion was performed for 3 wk before C. neoformans infection. Selective depletion of B-1 cells was confirmed by flow cytometry. The groups of B-1-depleted and control mice were infected i.n. with 5 3 10 5 CFU C. neoformans strain 24067 and euthanized on day 3 postinfection.
B-1a cell transfer
Total PerC cells from 6-to 8-wk-old C57BL/6 mice were isolated and stained with CD45-Pacific Blue, CD19-PE-Cy7, B220-PerCP-Cy5. 
Phagocytosis analysis and fungal burden
Alveolar macrophages were isolated from the lung lavage fluid of mice euthanized on day 3 postinfection as described previously (27) . Macrophages were allowed to attach on slide chambers (Lab-Tek) for 2 h, fixed with methanol, and stained with Giemsa. Cells were examined under 403 magnification. The phagocytic index (PI) was defined as the number of internalized C. neoformans cells per 100 macrophages counted. After collecting the lung lavages, lungs and brains were removed and homogenized in 1 ml HBSS (Lonza). CFUs were determined by making 10-fold serial dilutions of each tissue and plating 20 ml dilutions on Sabouraud dextrose agar plates in duplicate. Plates were incubated at room temperature for 72 h, after which colonies were visually counted.
Statistical analysis
All statistical analyses were performed using Prism (GraphPad Software). For comparisons between two groups, a Student t test was used. Multigroup comparisons of mean values were made using one-way ANOVA followed by a Bonferroni posttest. Gene family usage and N nucleotide additions were compared using the x 2 test as described (56) . All combinations were compared in 2 3 2 contingency tables. For statistical evaluations, p , 0.05 was considered significant.
Results
The early B cell response to C. neoformans is most robust in PerC B-1 B cells Total B, B-2, B-1a, and B-1b B cells in lungs, medLN, spleen, and PerC of naive and day 7 C. neoformans-infected C57BL/6 mice were quantified to identify sites of the early B cell response to C. neoformans. There was an increase of total lymphocytes in medLN on day 7 postinfection, which was mainly limited to the B-2 subpopulation (Fig. 1A) . Total B-1a, B-1b, and B-2 cell numbers increased in lungs on day 7, but they were comparable in spleen and PerC of C. neoformans-infected and naive mice (Fig. 1B-D) . We next analyzed earlier times and found a significant increase in total PerC B-1a, B-1b, and B-2 cells on day 1 postinfection that peaked on day 3 postinfection (Fig. 1C) . Differences in lung B-1a, B-1b, and B-2 cells in infected and control mice on day 1 were not statistically significant (Fig. 1D) , and the increase in lung total B, B-2, and B-1 cells seen on day 3 did not reach statistical significance for B-1a cells (Fig. 1D) .
ELISPOTS were used to determine whether C. neoformans infection-induced B cells observed in PerC, spleen, medLN, and lungs produced IgM that bound to GXM-and heat-killed capsular (24067) and acapsular (Cap67) C. neoformans. On day 3 postinfection, PerC and splenic B cells were the main source of C. neoformans-binding IgM (Fig. 1E) . Because PerC B cells were increased by day 1 postinfection and were the main source of C. neoformans-binding IgM, subsequent analyses were performed on PerC cells.
The early B cell response to C. neoformans is due to recruitment
We examined the rate of BrdU incorporation on day 3 postinfection to establish whether the increase in PerC B cells in C. neoformansinfected mice was due to migration and recruitment of B cells or clonal expansion. BrdU incorporation was not significantly different in naive (sham-infected) and infected mice (1.7 versus 2.5% for total B cells, 0.57 versus 0.89% for B-2 cells, 3 versus 5% for B-1a cells, and 1.8 versus 2.6% for B-1b cells). Hence, the increase in B cells reflected recruitment.
PerC B-1a B cells have the highest frequency of C. neoformans-binding cells
To investigate whether the B cells recruited to PerC in C. neoformans-infected mice were selected owing to an intrinsic capacity for C. neoformans binding, we used GFP-labeled capsular 24067 (GFP-24067) and Uvitex-labeled acapsular Cap67 (UvitexCap67) strains to select, respectively, capsular and acapsular C. neoformans-binding B-1a, B-1b, and B-2 cells by flow cytometry (Fig. 2) . Both strains were used to identify differences in the frequency of B-1a, B-1b, and B-2 B cells that bind capsular and acapsular (cell wall) Ags. Compared to naive mice, on day 3 postinfection, frequencies of total PerC acapsular C. neoformansbinding B-1a, B-1b, and B-2 cells increased from 0.05 to 0.30%, 0.03 to 0.17%, and 0.06 to 0.25%, respectively ( Fig. 2A) . Although the fraction of both capsular and acapsular C. neoformans- (Fig. 2D) . C. neoformans-selected cells also showed increased binding to GXM-and heat-killed 24067 and Cap67 C. neoformans cells compared with unselected cells (data not shown). Hence, C. neoformans-selected cells produced IgM that bound to C. neoformans Ags. Table I ). Fig. 3 shows IgV H gene family frequencies in unselected, acapsular, and capsular C. neoformans-selected B-1a, B-1b, and B-2 cells. J558 (V H 1) usage predominated in unselected B-2 (40%; Fig. 3A) , B-1a (33.3%; Fig. 3B ), and B-1b cells (41%; Fig. 3C ) with frequencies similar to expected germline frequencies (56) . Acapsular C. neoformans-selected B-2 cells had evidence of Ag-driven selection, with a significantly higher frequency of J558 genes (83%; Fig. 3D ) than unselected (40%, p = 0.02; Fig.  3A ) and capsular C. neoformans-selected B-2 cells (27%, p = 0.02; Fig. 3G ). Capsular C. neoformans-selected B-2 B cells had a higher frequency of Q52 (18 versus 0%), 7183 (9 versus 7%), and S107 (18 versus 7%) gene use than did unselected B-2 cells (Fig. 3G) .
For B-1a cells, J558 gene use was similar in unselected (33%; Fig. 3B ), acapsular (22%; Fig. 3E ), and capsular (20%; Fig. 3H ) C. neoformans-selected cells. However, acapsular C. neoformansselected B-1a cells had more V H 11 gene use (22%; Fig. 3E ) than did unselected cells (11%; Fig. 3B) , and capsular C. neoformansselected B-1a cells had 10-fold more V H 12 gene use (33%; Fig.  3H ) than did unselected cells (3%, p = 0.02; Fig. 3B Fig. 3C ), acapsular (40%; Fig. 3F ), and capsular (36%; Fig. 3I ) C. neoformans-selected cells. There were no differences in the use of other gene families among C. neoformans-selected and unselected B-1b cells.
There were no differences in D H or J H gene use in unselected and C. neoformans-selected B-1a, B-1b, and B-2 cells (Supplemental Figs. 1, 2) , and patterns of use were similar to previous reports (56, 57) . Most B cells analyzed used the DSP and DFL16 family D H gene segments. Increased J H 1 usage (60%) observed in GFP-24067 + B-1a cells was due to preferential pairing of V H 11 and V H 12 genes with J H 1.
B cells that bind acapsular and capsular C. neoformans differ in their clan derivation
Because it has been hypothesized that clans of structurally related Igs bind defined antigenic determinants (58), we classified the V H gene family usage of the B cell subsets described above into these clans (Fig. 4) . Compared to unselected cells, there was increased clan I/J558 usage in acapsular C. neoformans-selected B-2 cells (92 versus 75%; Fig. 4D and Fig. 4A, respectively) and B-1b cells (55 versus 45%; Fig. 4F and Fig. 4C ). In contrast, increased clan II gene use was seen in capsular C. neoformans-selected B-2 (18 versus 11%; Fig. 4G and Fig. 4A) , B-1a (47 versus 23%; Fig. 4H and Fig. 4B ), and B-1b (28 versus 17%; Fig. 4I and Fig. 4C ) cells compared with unselected counterparts. Increased clan III usage in acapsular C. neoformans-selected B-1a cells did not reach statistical significance (39 versus 30%; Fig. 4E and Fig. 4B ). 
HCDR3 regions of C. neoformans-selected and unselected B-1a cells vary in glycine content and length
Because PerC B-1a cells had the most C. neoformans-selected cells among the B cell populations analyzed, we examined their HCDR sequences to gain further insight into their role in C. neoformans binding (Supplemental Table II ). All 68 B-1a B cell sequences were essentially germline. Compared to unselected cells, C. neoformans-selected B-1a cells had a significantly higher frequency of glycine residues (11 versus 6%, p = 0.03). HCDR2 sequences were analyzed to detect residues I51, G54, Y58, Y59, D61, and V63, which were conserved in human and mouse GXMbinding mAbs (17, 59) . Residues I51 and Y59 were conserved in 95 and 100%, respectively, of all 68 B-1a sequences. G54 was conserved in both acapsular (48%) and capsular (53%) C. neoformans-selected B-1a cells compared with unselected (36%) B-1a sequences. No significant conservation was observed for Y58, D61, and V63 or HCDR3 residues R95 and D96. Consistent with other reports (56, 57) , HCDR3 lengths of B-1a (average, 10.8 6 2.6 codons) were shorter than those of B-2 and B-1b cells. HCDR3 lengths of 11 aas were more frequent in acapsular C. neoformansselected B-1a (26 versus 13%) than unselected cells, and lengths of 12 aas were more frequent in capsular C. neoformans-selected B-1a (33 versus 16%) than unselected cells (Fig. 5A-C) .
N nucleotide additions differ in acapsular and capsular C. neoformans-selected B-1a subsets N nucleotides increase HCDR3 length and generate junctional diversity (60) . In our analysis, shorter HCDR3 lengths in B-1a cells were associated with fewer N additions. Sequences having three or fewer N additions were considered close to germline. More B-1a cells (56%) had three or fewer N additions than did B-2 (22%, p , 0.01) and B-1b (35%, p = 0.02) cells, and there were fewer N additions in acapsular and capsular C. neoformans-selected B-1a cells (average, 2.5 versus 4.0) than in unselected B-1a cells. Most (57%) unselected B-1a cells had more than three N nucleotides compared with 40% of acapsular and only 26% of capsular C. neoformans-selected B-1a cells (Fig. 5D) , demonstrating that capsular C. neoformans-selected B-1a cells were significantly more germline than were unselected (p , 0.05) and acapsular C. neoformans-selected B-1a cells, although the latter difference was not statistically significant.
Depletion of B-1 cells results in increased fungal burden and reduced phagocytosis
To establish a mechanistic role for B-1a cells in our model, we depleted mice of pleural and PerC B-1 cells and compared fungal burdens and alveolar macrophage phagocytosis of C. neoformans http://www.jimmunol.org/ in depleted and undepleted (control) mice. After 3 wk depletion, B-1 cell numbers were lower in B-1-depleted mice (30%) than in undepleted mice by flow cytometry (Fig. 6A, 6B) . B-1-depleted mice had more CFU in lung (p = 0.002) and brain (p = 0.01) 3 d after C. neoformans infection (Fig. 6C, 6D ). Because in vivo phagocytosis is a correlate of survival in pulmonary C. neoformans infection models (27, 61), we also determined phagocytosis ex vivo. Alveolar macrophages from control mice had a significantly higher PI than did B-1-depleted mice (p = 0.04; Fig. 6E ). Next, we reconstituted B-1 B cell-depleted mice with B-1a B cells and evaluated the same parameters. Lung (p = 0.005) and brain (p = 0.03) CFU were lower in B-1a B cell-reconstituted than in B-1 B cell-depleted mice, and B-1a B cell-reconstituted mice had significantly more alveolar phagocytosis than did B-1-depleted mice (p = 0.02; Fig. 6H ).
Discussion
Our data provide direct evidence that B-1a cells contribute to early clearance of C. neoformans in a pulmonary infection model. B-1 B cell-depleted C. neoformans-infected mice had higher fungal burdens and less robust alveolar macrophage phagocytosis of C. neoformans than did control and B-1a-reconstituted B-1 B celldepleted mice. Hence, as described for other pathogens (22, 45, 62) , B-1a B cells also provide a first line of defense against pulmonary C. neoformans infection in mice. Cells from PerC and spleen showed increased IgM production in response to C. neoformans infection. Because C. neoformans-infected mice exhibited an early increase in IgM-secreting PerC B-1 B cells, and a previous study demonstrated that natural IgM enhanced alveolar macrophage phagocytosis of C. neoformans in IgM-deficient mice (27) , our findings suggest that B-1a B cells enhance innate antifungal immunity via natural IgM. Consistent with murine influenza virus studies (23, (62) (63) (64) , the increases in PerC and lung B-1 B cells in our model were due to recruitment, rather than to clonal expansion. Although the mechanism by which B-1 B cells traffic to C. neoformans-infected lungs requires additional study, PerC B-1 cells migrate in response to chemokines, can differentiate into phagocytes that move to inflammatory loci (65) (66) (67) (68) , and have been shown to kill C. neoformans in vitro (40) . B-1 B cell-derived IgM bound to acapsular and capsular C. neoformans cells, GXM, and laminarin. However, it is likely that laminarin, a b-1,3-glucan that is part of the C. neoformans cell wall (13) , was a main capsular and acapsular C. neoformans IgM binding determinant. mAbs to laminarin bound to C. albicans, A. fumigatus, and C. neoformans and protected mice from lethal Candida and C. neoformans infection (13, 14, 29, 69) . We were not able to discriminate between B-1a-and B-1b-derived C. neoformans-binding IgM owing to the limited number of B-1a and B-1b cells recovered. In other mouse models, CD5 + (B-1a) B cells produced laminarin-reactive IgM after Pneumocystis infection (22) and B-1a cells mediated protection against Francisella tularensis (45), but B-1b cells protected against Borrelia hermsii (70, 71) and B-1a and B-1b cells had different roles in resistance to Streptococcus pneumoniae. For the latter, B-1a cells mediated protection via natural Abs to phosphorylcholine and B1b cells generated capsular polysaccharide Abs (35) . It is possible that B-1b cells were also responsible for capsular polysaccharide (GXM) reactivity in our model, but technical challenges prevented us from isolating GXM + B cells. Sequence analysis of C. neoformans-binding B-1a B cells revealed V H restriction, albeit to different V H genes than those used in GXM mAbs (16) . Interestingly, the gene element (V H 7183) used in the GXM-elicited repertoire was only slightly increased in capsular C. neoformans-selected B-2 cells, suggesting that GXM determinants that are targets of the adaptive response are not a predominant focus of the early innate B cell response. We were not able to study GXM-selected B cells. Alternatively, the minimal increase in C. neoformans-selected B cells expressing V H genes used in GXM mAbs could indicate that capsular polysaccharide determinants are recognized differently in the context of whole organism as described for another encapsulated pathogen (72, 73) . Although the biological significance of V H restriction is not known, many restricted responses are focused on conserved microbial determinants, such as a-1,3-dextran (J558/V H 1), phos- phorylcholine (T15/V H 7), and PC (V H 11 and V H 12) (74). Strikingly, acapsular C. neoformans-selected B-1a B cells used V H 11 genes, whereas capsular C. neoformans-selected cells used V H 12 genes. V H 11 and V H 12 gene segments each confer specificity for PC (74, 75) , and B-1a cells produce natural Abs to PC (76), a mammalian and bacterial membrane phospholipid that has also been discovered in C. neoformans vesicles (77) . Because the restricted repertoire of PC-reactive B-1 cells and their predominant pairing with J H 1 is thought to enable B-1 cells to respond to microbial Ags (78), PC-rich C. neoformans vesicles could shape the early B cell response to C. neoformans.
Although V H 11 and V H 12 gene segments are both implicated in PC binding, they belong to different Ig clans (58), with V H 11 belonging to clan III and V H 12 belonging to clan II. The difference in V H gene usage that we observed among acapsular (V H 11) and capsular (V H 12) C. neoformans-selected B-1a cells suggests that different PC-like determinants are recognized in each case and/or that PC is recognized differently in the context of capsular polysaccharide. The latter has been demonstrated for the response to pneumococcal proteins (79) . However, we note that GFP-24067 (capsular C. neoformans) could have captured B cells recognizing capsular as well as cell wall components. Our data indicate that glucans present on the C. neoformans cell wall (80) also shape the early C. neoformans response as reflected by laminarin (b-glucan) binding of C. neoformans-selected B-1 B cells. Furthermore, and in contrast to capsular C. neoformans-selected B-1 cells, acapsular C. neoformans-selected B-1b and B2 cells exhibited predominant use of clan I/V H J558. As natural Abs to a-1,3-dextran use clan I/J558 gene segments (81, 82) and a-1,3-glucans are present on the C. neoformans cell wall (83, 84) , our data suggest that acapsular C. neoformans-selected B-2 and B-1b cells bind Ags that are discrete from those recognized by B-1a B cells.
HCDR3 regions, which are critical for Ag recognition (85) , are biased to the use of neutral, hydrophilic amino acids such as tyrosine, glycine, and serine and against the use of highly charged and hydrophobic amino acids (86, 87) . Our data show that glycine use was much higher in C. neoformans-selected than in unselected cells, corroborating previous data that carbohydrate-binding CDR3s preferentially use hydrophilic amino acids (51) . Consistent with studies showing that HCDR2 residues are also critical for the generation of human and mouse Abs to GXM (17, 59), we found that the HCDR2 residues I51, G54, and Y59 were conserved in C. neoformans-binding B-1a cells. Thus, our data support the concept that V H as well as HCDR2 and HCDR3 each confer binding to C. neoformans determinants (88) . Furthermore, as restriction in HCDR3 length is indicative of Ag-driven selection, our finding that capsular C. neoformans-selected cells had shorter HCDR3 lengths than did acapsular C. neoformans-selected cells provides further evidence that capsular and acapsular C. neoformans select distinct germline B cell repertoires.
There was no evidence of somatic hypermutation in any of the B-1a cells we studied. As human GXM-binding mAbs derived from XenoMouse mice also used germline V H gene segments (17) , our data further demonstrate that restricted V H genes and conserved HCDR structures are sufficient to bind C. neoformans determinants. Our data also confirm reports that B-1a cells have a low frequency of N nucleotides (56, 57) and reveal that acapsular C. neoformans-selected B-1a cells had more N nucleotides than did capsular C. neoformans-selected cells. Thus, TdT activity could be more important for binding to b-glucan and/or other C. neoformans cell wall determinants than GXM. Consistent with the latter, TdT was required for optimal Ab responses to the a-glucan dextran (89). As noted above, the molecular features of acapsular and capsular C. neoformans-binding B-1a cells differed from those observed for GXM-binding mAbs generated from GXM-TT vaccinated mice, which mainly used 7183 V H , a member of clan III (15, 16, 90) . Similarly, human mAbs elicited by a GXM conjugate (in XenoMouse mice) used V H 3 and V H 6, members of clans III and II, respectively (17) . In this study, the increase in clan III use only reached statistical significance for C. neoformans-selected B-2 cells. Hence, the molecular features of "innate" and "adaptive" responses to C. neoformans differ. The adaptive response, as exemplified by GXM-binding mAbs, is derived from clan III genes, whereas the innate response, as reported in this study, is dominated by B-1a cells expressing germline clan I and II genes. As the innate response is likely to be stimulated by cell wall carbohydrate (glucans) and/or phosphorylated determinants (e.g., PC), our data are consistent with reports that the primary and secondary responses of B-1a cells are distinct from B-2 cells (91, 92) .
To our knowledge, this study is the first to establish a role for the germline B-1 repertoire in the innate response to C. neoformans, as our data show that B-1a B cells contribute to fungal clearance and enhance phagocytosis of C. neoformans in the lungs. Given that IgM memory B cells are a major source of natural IgM (21, 38) , our findings provide a potential explanation for the observation that loss of IgM memory B cells was associated with risk for HIVassociated cryptococcosis (24) . More work is needed to discriminate between the contributions of B-1a B cells and IgM in host defense against C. neoformans and to identify the precise C. neoformans determinants that B-1a B cells recognize. Nonetheless, our discovery that the naturally occurring B cell repertoire has the ability to respond to C. neoformans has broad implications for our understanding of the pathogenesis of C. neoformans and advancing new approaches to treat and prevent cryptococcosis.
